MERUS NV (MRUS) Stock Price, Quote, News and Overview
NASDAQ:MRUS - Nasdaq - NL0011606264 - Common Stock - Currency: USD
MRUS Quote, Performance and Key Statistics
55.39
+0.34 (+0.62%)
The current stock price of MRUS is 55.39 USD. In the past month the price increased by 37.1%. In the past year, price decreased by -2.05%.
MRUS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.74 | 339.89B | ||
| AMGN | AMGEN INC | 14.32 | 159.86B | ||
| GILD | GILEAD SCIENCES INC | 14.48 | 139.38B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 118.14B | ||
| REGN | REGENERON PHARMACEUTICALS | 11.78 | 56.34B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 39.73B | ||
| ARGX | ARGENX SE - ADR | 102.05 | 35.83B | ||
| ONC | BEONE MEDICINES LTD-ADR | 7.07 | 29.91B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.22B | ||
| NTRA | NATERA INC | N/A | 22.44B | ||
| BIIB | BIOGEN INC | 8.36 | 19.39B | ||
| INSM | INSMED INC | N/A | 17.65B |
Related stock screener links
About MRUS
Company Profile
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. The company is headquartered in Utrecht, Utrecht and currently employs 260 full-time employees. The company went IPO on 2016-05-19. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The firm operates in the Netherlands and United States.
Company Info
MERUS NV
Uppsalalaan 17, 3rd & 4th floor
Utrecht UTRECHT 3584 NL
CEO: Sven A. Lundberg
Employees: 291
Phone: 31850162500
MERUS NV / MRUS FAQ
What is the stock price of MERUS NV today?
The current stock price of MRUS is 55.39 USD. The price increased by 0.62% in the last trading session.
What is the ticker symbol for MERUS NV stock?
The exchange symbol of MERUS NV is MRUS and it is listed on the Nasdaq exchange.
On which exchange is MRUS stock listed?
MRUS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MERUS NV stock?
24 analysts have analysed MRUS and the average price target is 91.42 USD. This implies a price increase of 65.04% is expected in the next year compared to the current price of 55.39. Check the MERUS NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MERUS NV worth?
MERUS NV (MRUS) has a market capitalization of 3.83B USD. This makes MRUS a Mid Cap stock.
How many employees does MERUS NV have?
MERUS NV (MRUS) currently has 291 employees.
What are the support and resistance levels for MERUS NV (MRUS) stock?
MERUS NV (MRUS) has a support level at 55.38 and a resistance level at 60. Check the full technical report for a detailed analysis of MRUS support and resistance levels.
Is MERUS NV (MRUS) expected to grow?
The Revenue of MERUS NV (MRUS) is expected to grow by 53.76% in the next year. Check the estimates tab for more information on the MRUS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MERUS NV (MRUS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MRUS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MRUS, evaluating the profitability, health, valuation and growth aspects
- MERUS NV (MRUS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MERUS NV (MRUS) Sales and EPS estimates to see what analysts future expectations are.
- MERUS NV (MRUS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MERUS NV (MRUS) Insider and Institutional Ownership to learn about the owners and their transactions.
- MERUS NV (MRUS) Stock Chart to make your own analysis
- MERUS NV (MRUS) Latest news and press-releases to stay up to date.
Does MERUS NV (MRUS) stock pay dividends?
MRUS does not pay a dividend.
When does MERUS NV (MRUS) report earnings?
MERUS NV (MRUS) will report earnings on 2025-07-30, after the market close.
What is the Price/Earnings (PE) ratio of MERUS NV (MRUS)?
MERUS NV (MRUS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.12).
What is the Short Interest ratio of MERUS NV (MRUS) stock?
The outstanding short interest for MERUS NV (MRUS) is 8.49% of its float. Check the ownership tab for more information on the MRUS short interest.
MRUS Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to MRUS. When comparing the yearly performance of all stocks, MRUS turns out to be only a medium performer in the overall market: it outperformed 64% of all stocks.
MRUS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MRUS. MRUS has a great financial health rating, but its profitability evaluates not so good.
MRUS Financial Highlights
Over the last trailing twelve months MRUS reported a non-GAAP Earnings per Share(EPS) of -4.12. The EPS decreased by -51.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -37.94% | ||
| ROE | -46.52% | ||
| Debt/Equity | 0 |
MRUS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 88% to MRUS. The Buy consensus is the average rating of analysts ratings from 24 analysts.
For the next year, analysts expect an EPS growth of -33.69% and a revenue growth 53.76% for MRUS